Director, Nonclinical Development
Company: Amber Bio
Location: Alameda
Posted on: November 26, 2025
|
|
|
Job Description:
Job Description Amber Bio is a biotechnology company pioneering
new gene editing modalities using multi-kilobase edits to reach
previously undruggable patient populations. Founded by pioneers in
the CRISPR field from leading institutions for gene editing
research, the company is developing a first-of-its-kind RNA editing
platform that can correct thousands of bases at once, thereby
correcting genetic mutations safely and reversibly. Multiple
openings are available on a rapidly growing team. If you are
interested in building a new frontier in genetic medicine, please
apply via LinkedIn. Job Description: Director, Nonclinical
Development Position Overview: We are seeking an experienced and
highly motivated Director of Nonclinical Development to lead
preclinical activities supporting our RNA editing pipeline. The
successful candidate will design and oversee nonclinical
pharmacology, biodistribution, and toxicology studies, ensuring
timely and high-quality execution to support IND submissions.
Reporting into the VP of Development, the candidate will provide
both strategic leadership and hands-on management in a fast-paced
startup environment, partnering closely with discovery, analytical,
and manufacturing teams. Key Responsibilities: Study Design &
Oversight Design, oversee, and interpret preclinical studies
(non-GLP and GLP), including pharmacology, biodistribution, and
toxicology studies Select, negotiate, and manage CROs and external
partners Write, review, and edit preclinical study reports and
nonclinical sections of regulatory submissions Ensure data,
methods, studies, and reports meet FDA, EMA, and ICH guidelines
Strategic Leadership Define and implement the nonclinical
development strategy for RNA editing programs from candidate
selection through IND submission Identify key risks, mitigation
strategies, and timelines for nonclinical workstreams Maintain
up-to-date knowledge of regulatory guidance and emerging science in
RNA editing, gene therapy, and AAV biology Collaboration &
Communication Partner with discovery scientists to inform candidate
selection strategy Work with manufacturing and analytical teams to
ensure efficient hand-offs and successful integration of data
across functions Communicate findings and recommendations clearly
to project teams, leadership, and external stakeholders
Qualifications: PhD in Pharmacology, Toxicology, Biology, or
related discipline 8-12 years of experience in preclinical
development, with at least 5 years in a biotech/pharma environment
Experience in drug development for ocular and CNS indications
Demonstrated track record of designing, monitoring, and
interpreting preclinical safety & efficacy studies for IND
submissions Strong understanding of FDA and ICH guidance on gene
therapy Proven success in managing CROs and vendors for GLP/non-GLP
studies Experience integrating nonclinical data into regulatory
submissions Ability to synthesize complex data sets and communicate
effectively across functions Ability to travel up to 25% of the
time Preference will be given to those who display: High
motivation, with a strong work ethic and dedication to generating
impact Attention to detail, with the ability to extract deep
insights from data Ability to go from ideation to data in an
independent fashion Long-term personal vision with defined career
goals Team-oriented thinking Demonstrated excellence in small team
environments, including a “no task is too small” attitude If you
have a passion for advancing gene editing technologies and desire
to be part of a pioneering biotech company, we encourage you to
apply and join our ambitious team. Please apply directly through
LinkedIn. Amber Bio is an equal-opportunity employer and encourages
applications from candidates of diverse backgrounds. We value
diversity and are committed to creating an inclusive and supportive
work environment for all employees.
Keywords: Amber Bio, Alameda , Director, Nonclinical Development, Science, Research & Development , Alameda, California